FDA approves Roche drug for late-stage metastatic breast cancer
February 22, 2013 at 09:39 AM EST
Feb 22 (Reuters) - U.S. health regulators said on Friday they have approved a new drug made by Roche Holding AG for some patients with late-stage metastatic breast cancer who have failed other therapies.
